Laura Else

2.5k citations

84 papers · 1.6k indexed · h-index 25

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Virology 38
- HIV Research and Treatment 38
Infectious Diseases 78
- HIV/AIDS drug development and treatment 59
- HIV/AIDS Research and Interventions 35

Co-authors: David Back (47 shared papers)Saye Khoo (63 shared papers)Marta Boffito (26 shared papers)Alieu Amara (23 shared papers)Stephen Taylor (5 shared papers)Victoria Watson (5 shared papers)Sujan Dilly Penchala (18 shared papers)Marco Siccardi (7 shared papers)
Journals: Journal of Antimicrobial Chemotherapy (17 papers)Antimicrobial Agents and Chemotherapy (9 papers)Antiviral Therapy (7 papers)Clinical Infectious Diseases (5 papers)Journal of Chromatography B (5 papers)
Partner nations: United Kingdom United States Uganda

In The Last Decade

Laura Else

82 papers receiving 1.6k citations

Peers

Countries citing papers authored by Laura Else

Since Specialization

Citations

This map shows the geographic impact of Laura Else's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Else with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Else more than expected).

Fields of papers citing papers by Laura Else

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Else. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Else. The network helps show where Laura Else may publish in the future.

Co-authors

The 25 scholars most cited alongside Laura Else, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Laura Else Line = papers co-authored together Laura Else links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Validation of a rapid and sensitive high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds Journal of Chromatography B ·Laura Else, Victoria Watson, John Tjia, Andrew T. Hughes, Marco Siccardi, Saye Khoo, David Back	2010	114
2	Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Male and Female Genital Tract Antiviral Therapy ·Laura Else, Stephen Taylor, David Back, Saye Khoo	2011	95
3	A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis Clinical Pharmacology & Therapeutics ·Akil Jackson, Laura Else, Pedro M. M. Mesquita, Deirdre Egan, David Back, Zeenat Karolia, Lisa Ringner-Nackter, Chris Higgs, Betsy C. Herold, B G Gazzard, Marta Boffito	2014	89
4	Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks Clinical Infectious Diseases ·Kimberly K. Scarsi, Kristin M. Darin, Shadia Nakalema, David Back, Pauline Byakika‐Kibwika, Laura Else, Sujan Dilly Penchala, Allan Buzibye, Susan E. Cohn, Concepta Merry, Mohammed Lamorde	2015	67
5	The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva Journal of Pharmaceutical and Biomedical Analysis ·Alieu Amara, Sujan Dilly Penchala, Laura Else, Colin Hale, Richard J. Fitzgerald, Lauren Walker, Rebecca Lyons, Tom Fletcher, Saye Khoo	2021	61
6	Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study Clinical Pharmacology & Therapeutics ·Laura Dickinson, Janaki Amin, Laura Else, Marta Boffito, Deirdre Egan, Andrew Owen, SH Khoo, David Back, Catherine Orrell, Amanda Clarke, Marcelo Losso, Praphan Phanuphak, Dianne Carey, D. A. Cooper, Sean Emery, Rebekah Puls	2015	59
7	Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients AIDS ·Aylin Yilmaz, Victoria Watson, Laura Else, Magnus Gisslén	2009	50
8	Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid) Antiviral Therapy ·Laura Else, Stephen Taylor, David Back, Saye Khoo	2011	47
9	Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia Journal of NeuroVirology ·Sam Nightingale, Anna María Geretti, Apostolos Beloukas, Martin Fisher, Alan Winston, Laura Else, Mark Nelson, Stephen Taylor, Andrew Ustianowski, Jonathan Ainsworth, Richard Gilson, Lewis Haddow, Edmund Ong, Victoria Watson, Clifford Leen, Jane Minton, Frank A. Post, Munir Pirmohamed, Tom Solomon, Saye Khoo	2016	41
10	Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies Journal of Antimicrobial Chemotherapy ·Catriona Waitt, Paul Garner, Laura Bonnett, Saye Khoo, Laura Else	2015	41
11	Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study Clinical Pharmacokinetics ·Laura Dickinson, Janaki Amin, Laura Else, Marta Boffito, Deirdre Egan, Andrew Owen, Saye Khoo, David Back, Catherine Orrell, Amanda Clarke, Marcelo Losso, Praphan Phanuphak, Dianne Carey, David A. Cooper, Sean Emery, Rebekah Puls	2015	38
12	Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA) The Journal of Infectious Diseases ·Kerri J. Penrose, Urvi M. Parikh, Kristen A. Hamanishi, Laura Else, David Back, Marta Boffito, Akil Jackson, John W. Mellors	2015	34
13	The importance of drug–drug interactions in the DAA era Digestive and Liver Disease ·David Back, Laura Else	2013	32
14	Pharmacokinetics of Atazanavir/Ritonavir Once Daily and Lopinavir/Ritonavir Twice and once Daily over 72 h following drug Cessation Antiviral Therapy ·Marta Boffito, Laura Else, David Back, Jessica Taylor, Saye Khoo, Marta Sousa, Anton Pozniak, Brian Gazzard, Graeme Moyle	2008	31
15	Breast Milk Pharmacokinetics of Efavirenz and Breastfed Infants' Exposure in Genetically Defined Subgroups of Mother-Infant Pairs: An Observational Study Clinical Infectious Diseases ·Adeniyi Olagunju, Oluseye O. Bolaji, Alieu Amara, Catriona Waitt, Laura Else, Ebunoluwa A. Adejuyigbe, Marco Siccardi, David Back, Saye Khoo, Andrew Owen	2015	30
16	The development and application of a novel LC–MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma Journal of Chromatography B ·Sujan Dilly Penchala, Sandra Fawcett, Laura Else, Deirdre Egan, Alieu Amara, Emilie R Elliot, Elizabeth Challenger, David Back, Marta Boffito, Saye Khoo	2016	29
17	Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS Journal of Antimicrobial Chemotherapy ·Adeniyi Olagunju, Oluseye O. Bolaji, Alieu Amara, Catriona Waitt, Laura Else, Julius O. Soyinka, Babatunde Ayodeji Adeagbo, Ebunoluwa A. Adejuyigbe, Marco Siccardi, David Back, Andrew Owen, Saye Khoo	2014	29
18	Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study Antimicrobial Agents and Chemotherapy ·Laura Else, Akil Jackson, Rebekah Puls, Andrew Hill, Paul Fahey, Enmoore Lin, Alieu Amara, Marco Siccardi, Victoria Watson, John Tjia, Sean Emery, Saye Khoo, David Back, Marta Boffito	2011	28
19	Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers Journal of Antimicrobial Chemotherapy ·Laura Dickinson, Marta Boffito, D.J. Back, Laura Waters, Laura Else, Geraint Davies, Saye Khoo, Anton Pozniak, Leon Aarons	2009	28
20	Improved Oral Bioavailability of Lopinavir in Melt-Extruded Tablet Formulation Reduces Impact of Third Trimester on Lopinavir Plasma Concentrations Antimicrobial Agents and Chemotherapy ·Laura Else, Melanie Douglas, Laura Dickinson, David Back, Saye Khoo, Graham P. Taylor	2011	28

About Laura Else

Laura Else is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Hepatology and Pediatrics, Perinatology and Child Health, having authored 84 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (59 papers), HIV Research and Treatment (38 papers), HIV/AIDS Research and Interventions (35 papers), HIV-related health complications and treatments (12 papers), Pharmacological Effects and Toxicity Studies (11 papers), Hepatitis C virus research (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and HIV, Drug Use, Sexual Risk (5 papers). The work is most often cited by research in Virology (711 citations), Infectious Diseases (1.2k citations), Emergency Medicine (200 citations), Pediatrics, Perinatology and Child Health (261 citations) and Epidemiology (353 citations). Laura Else has collaborated with scholars based in United Kingdom, United States and Uganda. Frequent co-authors include David Back, Saye Khoo, Marta Boffito, Alieu Amara, Stephen Taylor, Victoria Watson, Sujan Dilly Penchala, Marco Siccardi, Akil Jackson and John Tjia. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Antiviral Therapy, Clinical Infectious Diseases and Journal of Chromatography B.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact